Rutger M. Schepp

1.7k total citations
37 papers, 931 citations indexed

About

Rutger M. Schepp is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Rutger M. Schepp has authored 37 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 12 papers in Infectious Diseases and 9 papers in Surgery. Recurrent topics in Rutger M. Schepp's work include Respiratory viral infections research (13 papers), Cervical Cancer and HPV Research (9 papers) and Viral gastroenteritis research and epidemiology (7 papers). Rutger M. Schepp is often cited by papers focused on Respiratory viral infections research (13 papers), Cervical Cancer and HPV Research (9 papers) and Viral gastroenteritis research and epidemiology (7 papers). Rutger M. Schepp collaborates with scholars based in Netherlands, United States and Guinea-Bissau. Rutger M. Schepp's co-authors include Fiona van der Klis, Guy A. M. Berbers, Mirte Scherpenisse, Liesbeth Mollema, Chris J.L.M. Meijer, Madelief Mollers, Richarda M. de Voer, Gerco den Hartog, Hester E. de Melker and Marion Koopmans and has published in prestigious journals such as The Lancet, PLoS ONE and Scientific Reports.

In The Last Decade

Rutger M. Schepp

37 papers receiving 916 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rutger M. Schepp Netherlands	19	567	315	175	154	149	37	931
Vana Spoulou Greece	20	546 1.0×	368 1.2×	98 0.6×	152 1.0×	91 0.6×	59	1.1k
Lily Yin Weckx Brazil	15	1.1k 2.0×	353 1.1×	126 0.7×	250 1.6×	71 0.5×	53	1.6k
Ulrich Behre Germany	16	695 1.2×	244 0.8×	156 0.9×	98 0.6×	91 0.6×	27	899
Eithne MacMahon United Kingdom	19	606 1.1×	339 1.1×	104 0.6×	172 1.1×	61 0.4×	42	1.1k
Maria Moriondo Italy	25	1.5k 2.6×	405 1.3×	359 2.1×	124 0.8×	138 0.9×	85	2.0k
Luc Hessel France	18	642 1.1×	336 1.1×	335 1.9×	171 1.1×	87 0.6×	36	1.2k
Brandon Essink United States	15	397 0.7×	622 2.0×	69 0.4×	158 1.0×	39 0.3×	37	1.1k
Juliana Esperalba Spain	20	309 0.5×	330 1.0×	187 1.1×	40 0.3×	110 0.7×	77	801
Lindsay R. Grant United States	22	857 1.5×	225 0.7×	237 1.4×	101 0.7×	39 0.3×	65	1.2k
Miriam Wiese‐Posselt Germany	19	581 1.0×	464 1.5×	63 0.4×	102 0.7×	161 1.1×	45	1.1k

Countries citing papers authored by Rutger M. Schepp

Since Specialization

Citations

This map shows the geographic impact of Rutger M. Schepp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rutger M. Schepp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rutger M. Schepp more than expected).

Fields of papers citing papers by Rutger M. Schepp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rutger M. Schepp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rutger M. Schepp. The network helps show where Rutger M. Schepp may publish in the future.

Co-authorship network of co-authors of Rutger M. Schepp

This figure shows the co-authorship network connecting the top 25 collaborators of Rutger M. Schepp. A scholar is included among the top collaborators of Rutger M. Schepp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rutger M. Schepp. Rutger M. Schepp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Verheul, Marije K., Joanna Kaczorowska, Marloes I. Hofstee, et al.. (2024). Protective mucosal SARS-CoV-2 antibodies in the majority of the general population in the Netherlands. Mucosal Immunology. 17(4). 554–564. 4 indexed citations

Dijk, Laura L.A. van, Laurine C. Rijsbergen, Katharina S. Schmitz, et al.. (2024). Virus neutralization assays for human respiratory syncytial virus using airway organoids. Cellular and Molecular Life Sciences. 81(1). 267–267. 5 indexed citations

Schepp, Rutger M., Joanna Kaczorowska, Pieter G. M. van Gageldonk, et al.. (2023). Effect of Palivizumab Prophylaxis on Respiratory Syncytial Virus Infection in Very Preterm Infants in the First Year of Life in The Netherlands. Vaccines. 11(12). 1807–1807. 2 indexed citations

Schepp, Rutger M., Cornelis A. M. de Haan, Robert S. van Binnendijk, et al.. (2023). Difference in respiratory syncytial virus-specific Fc-mediated antibody effector functions between children and adults. Clinical & Experimental Immunology. 214(1). 79–93. 6 indexed citations

Andeweg, Stijn P., Rutger M. Schepp, Jan van de Kassteele, et al.. (2021). Population-based serology reveals risk factors for RSV infection in children younger than 5 years. Scientific Reports. 11(1). 8953–8953. 58 indexed citations

Hartog, Gerco den, Rutger M. Schepp, Marjan Kuijer, et al.. (2020). SARS-CoV-2–Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence. The Journal of Infectious Diseases. 222(9). 1452–1461. 80 indexed citations

Erp, Elisabeth A. van, Mads Delbo Larsen, Rutger M. Schepp, et al.. (2020). Natural killer cell activation by respiratory syncytial virus‐specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc‐glycosylation. Clinical & Translational Immunology. 9(2). e1112–e1112. 28 indexed citations

Schepp, Rutger M., Guy A. M. Berbers, José A. Ferreira, Johan Reimerink, & Fiona van der Klis. (2016). A novel multiplex poliovirus binding inhibition assay applicable for large serosurveillance and vaccine studies, without the use of live poliovirus. Journal of Virological Methods. 241. 15–23. 10 indexed citations

Heijstek, Marloes W, Mirte Scherpenisse, Noortje Groot, et al.. (2013). Immunogenicity and safety of the bivalent HPV vaccine in female patients with juvenile idiopathic arthritis: a prospective controlled observational cohort study. Annals of the Rheumatic Diseases. 73(8). 1500–1507. 43 indexed citations

10.

Scherpenisse, Mirte, Madelief Mollers, Rutger M. Schepp, et al.. (2013). Detection of systemic and mucosal HPV-specific IgG and IgA antibodies in adolescent girls one and two years after HPV vaccination. Human Vaccines & Immunotherapeutics. 9(2). 314–321. 36 indexed citations

11.

Scherpenisse, Mirte, Rutger M. Schepp, Madelief Mollers, et al.. (2013). Characteristics of HPV-Specific Antibody Responses Induced by Infection and Vaccination: Cross-Reactivity, Neutralizing Activity, Avidity and IgG Subclasses. PLoS ONE. 8(9). e74797–e74797. 61 indexed citations

12.

Scherpenisse, Mirte, Madelief Mollers, Rutger M. Schepp, et al.. (2012). Changes in Antibody Seroprevalence of Seven High-Risk HPV Types between Nationwide Surveillance Studies from 1995–96 and 2006–07 in The Netherlands. PLoS ONE. 7(11). e48807–e48807. 14 indexed citations

13.

Scherpenisse, Mirte, Madelief Mollers, Rutger M. Schepp, et al.. (2012). Seroprevalence of seven high-risk HPV types in The Netherlands. Vaccine. 30(47). 6686–6693. 40 indexed citations

14.

Voer, Richarda M. de, Fiona van der Klis, Rutger M. Schepp, et al.. (2011). Age-Related Immunity to Meningococcal Serogroup C Vaccination: An Increase in the Persistence of IgG2 Correlates with a Decrease in the Avidity of IgG. PLoS ONE. 6(8). e23497–e23497. 10 indexed citations

15.

Voer, Richarda M. de, Fiona van der Klis, Rutger M. Schepp, et al.. (2009). Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults. Vaccine. 27(50). 6974–6982. 23 indexed citations

16.

Hijnen, Marcel, Qiushui He, Rutger M. Schepp, et al.. (2008). Antibody responses to defined regions of theBordetella pertussisvirulence factor pertactin. Scandinavian Journal of Infectious Diseases. 40(2). 94–104. 11 indexed citations

17.

Buisman, Anne‐Marie, et al.. (2008). Preexisting Poliovirus‐Specific IgA in the Circulation Correlates with Protection against Virus Excretion in the Elderly. The Journal of Infectious Diseases. 197(5). 698–706. 25 indexed citations

18.

Hijnen, Marcel, Richarda M. de Voer, Frits R. Mooi, et al.. (2007). The role of peptide loops of the Bordetella pertussis protein P.69 pertactin in antibody recognition. Vaccine. 25(31). 5902–5914. 19 indexed citations

19.

Widdowson, Marc‐Alain, Barry Rockx, Rutger M. Schepp, et al.. (2005). Detection of serum antibodies to bovine norovirus in veterinarians and the general population in the Netherlands. Journal of Medical Virology. 76(1). 119–128. 51 indexed citations

20.

Boot, Hein J., et al.. (2003). Rapid RT-PCR amplification of full-length poliovirus genomes allows rapid discrimination between wild-type and recombinant vaccine-derived polioviruses. Journal of Virological Methods. 116(1). 35–43. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact